Core 2 β(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis
View Patent ↗A method of indicating the presence of the atherosclerosis (particularly coronary artery atherosclerosis) in a subject is provided, comprising comparing the level of Core 2 GlcNAc-T in a tissue sample from a subject with a reference level determined for the same tissue. A level of Core 2 GlcNAc-T in the tissue sample from a subject that is higher than that of the reference level being indicative that the subject is afflicted with atherosclerosis (particularly coronary artery atherosclerosis—coronary artery disease—CAD). In preferred embodiments, the sample consists of leukocytes and the protein level is determined as the enzymatic activity using radiolabeled UDP-GlcNAc and a Galβ(1,3)-GalNAc derivative.
1. A method of indicating possible atherosclerosis in a subject comprising comparing the level of Core 2 GlcNAc-T enzyme activity in a blood sample from a subject with a reference enzyme activity level determined for a blood sample, wherein a level of Core 2 GlcNAc-T enzyme activity in the blood sample from a subject that is higher than the reference enzyme activity level being indicative that the subject may be afflicted with atherosclerosis.
2. A method according to claim 1 wherein the level of core 2 GlcNac-T enzyme activity is measured in leukocytes.
3. A method according to claim 2 in which the leukocytes are isolated from the blood.
4. A method according to claim 2 wherein a level of Core 2 GlcNAc-T enzyme activity of the leukocytes of a subject is at least 2 times higher than that of the reference level is indicative of atherosclerosis in the subject.
5. A method according to claim 2 wherein a level of Core 2 GlcNAc-T enzyme activity of the leukocytes of a subject is at least 4 times higher than that of the reference enzyme activity level is indicative of atherosclerosis in the subject.
6. A method according to claim 2 wherein a level of Core 2 GlcNac-T enzyme activity of the leukocytes of a subject is at least 2 times higher than that of the reference enzyme activity is indicative of atheroscleosis in the subject.
7. A method according to claim 2 wherein a level of Core 2 GlcNAc-T enzyme activity of the leukocytes of a subject is at least 8 times higher than that of the reference level is indicative of atherosclerosis in the subject.